Josh Ruben Appointed to the Board of Directors at PetVivo Holdings, Inc.

Written by Emily J. Thompson, Senior Investment Analyst

Source: Newsfilter

Updated: Oct 28 2025

0mins

Source: Newsfilter

New Board Member Announcement: PetVivo Holdings, Inc. has appointed Josh Ruben to its Board of Directors, bringing extensive experience in healthcare finance and corporate strategy to the company.
Expertise and Background: Ruben is the Managing Director of Life Sciences at Trinity Capital and has a strong background in investment banking, particularly in life sciences, with a history of executing significant M&A and capital transactions.
Company Focus and Strategy: PetVivo is dedicated to developing innovative medical devices and therapeutics for companion animals, leveraging human therapies to expedite market entry and revenue generation.
Product Pipeline: The company has a robust pipeline, including its lead product SPRYNG®, designed for managing joint-related conditions in animals, and aims to expand into human therapeutic markets.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.